The role of <i>Hath6</i>, a novel shear stress-responsive transcription factor, in endothelial differentiation and function modulation
Fang Fang(Montana State University), Xuetao Pei(Guangzhou Institutes of Biomedicine and Health), Kitchener D. Wilson(Stanford University), Brant M. Weinstein(Eunice Kennedy Shriver National Institute of Child Health and Human Development), Joseph C. Wu(Cardiovascular Institute of the South), Jesús Torres‐Vázquez(New York University), Feng Cao(Stanford University), Scott M. Wasserman(Amgen (United States)), Wen Yue(Guangzhou Institutes of Biomedicine and Health), Zongjin Li(Nankai University), Xiaoyan Xie(Cardiovascular Institute of the South)
Cited by 36
Related Papers
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
|New England Journal of Medicine|2017|6k
In Vivo Imaging of Embryonic Vascular Development Using Transgenic Zebrafish
|Developmental Biology|2002|2.2k
Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
|New England Journal of Medicine|2015|1.5k
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives
|Nature Reviews Cardiology|2020|1.5k